16 Nov 2017 Print this page Smiths Detection IONSCAN 600 First ‘Approved’ Explosives Trace Detector on New TSA Air Cargo Screening List Edgewood, MD – Smiths Detection’s IONSCAN 600 is the first explosives trace detection system to be ‘Approved’ on the TSA Air Cargo Screening Technology List (ACSTL) under the latest program requirements to ensure... Read more
Thu 16th November 2017 Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone, anywhere. To get closer to this, we want to abolish the cold chain so that our reagents can be transported easily to any researcher and be used in any environment. With this in mind, we are now starting... Read more
Metrohm Raman is pleased to announce its acquisition of Diagnostic anSERS inc. A subsidiary of Metrohm AG, Metrohm Raman is a key manufacturer of handheld Raman spectrometers based in Laramie, Wyoming. This acquisition expands the capabilities of our Mira Raman analyzers from instant materials identification to trace chemical analysis. Dr. Keith Carron, CEO of Metrohm... Read more
Download PDF November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist... Read more
SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology’s 2017 Annual Meeting (AMP), Edico Genome announced a new offering: the comprehensive DRAGEN Clinical Genomics Information System (CGIS). Designed to enable clinical laboratories of all sizes to quickly, simply and efficiently develop sequencing-based laboratory developed tests (LDTs), DRAGEN CGIS harnesses the power of... Read more
SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA... Read more
– Kit expands multiplexing options, allowing more biomarkers to be investigated on a single tissue slide – Multiplexed assays for simultaneously detecting several biomarkers in a single sample address growing need to obtain more information from limited tissue samples TUCSON, Arizona, Nov. 16, 2017 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the... Read more
November 16, 2017 8:12 A.M. Eastern Time RESEARCH TRIANGLE PARK, DURHAM, NC—(BUSINESS WIRE)—Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the European Patent Office has issued EPO Patent Nos. 1581612 and 2719756 covering the design of Xona’s products used for neuroscientific and... Read more
First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for... Read more
Improved optical sectioning delivers higher resolution without the need to acquire a z-stack JENA/Germany, 2017-11-15. At Neuroscience 2017, a new imaging mode for the ZEISS LSM 8 family with Airyscan has been introduced. Their unique 32-channel GaAsP array detector captures more spatial information than traditional confocal microscopes. The new 2D Superresolution mode now uses this... Read more